BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

798 related articles for article (PubMed ID: 15565649)

  • 1. SWI/SNF chromatin remodeling complex is obligatory for BMP2-induced, Runx2-dependent skeletal gene expression that controls osteoblast differentiation.
    Young DW; Pratap J; Javed A; Weiner B; Ohkawa Y; van Wijnen A; Montecino M; Stein GS; Stein JL; Imbalzano AN; Lian JB
    J Cell Biochem; 2005 Mar; 94(4):720-30. PubMed ID: 15565649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of potential modifiers of Runx2/Cbfa1 activity in C2C12 cells in response to bone morphogenetic protein-7.
    Gu K; Zhang L; Jin T; Rutherford RB
    Cells Tissues Organs; 2004; 176(1-3):28-40. PubMed ID: 14745233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo synergistic interactions between the Runx2/Cbfa1 transcription factor and bone morphogenetic protein-2 in stimulating osteoblast differentiation.
    Yang S; Wei D; Wang D; Phimphilai M; Krebsbach PH; Franceschi RT
    J Bone Miner Res; 2003 Apr; 18(4):705-15. PubMed ID: 12674331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reconstitution of Runx2/Cbfa1-null cells identifies a requirement for BMP2 signaling through a Runx2 functional domain during osteoblast differentiation.
    Bae JS; Gutierrez S; Narla R; Pratap J; Devados R; van Wijnen AJ; Stein JL; Stein GS; Lian JB; Javed A
    J Cell Biochem; 2007 Feb; 100(2):434-49. PubMed ID: 16927309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SWI/SNF-independent nuclease hypersensitivity and an increased level of histone acetylation at the P1 promoter accompany active transcription of the bone master gene Runx2.
    Cruzat F; Henriquez B; Villagra A; Hepp M; Lian JB; van Wijnen AJ; Stein JL; Imbalzano AN; Stein GS; Montecino M
    Biochemistry; 2009 Aug; 48(30):7287-95. PubMed ID: 19545172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-catenin and BMP-2 synergize to promote osteoblast differentiation and new bone formation.
    Mbalaviele G; Sheikh S; Stains JP; Salazar VS; Cheng SL; Chen D; Civitelli R
    J Cell Biochem; 2005 Feb; 94(2):403-18. PubMed ID: 15526274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The suppressive effect of myeloid Elf-1-like factor (MEF) in osteogenic differentiation.
    Kim YJ; Kim BG; Lee SJ; Lee HK; Lee SH; Ryoo HM; Cho JY
    J Cell Physiol; 2007 Apr; 211(1):253-60. PubMed ID: 17167770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of the two principal Runx2/Cbfa1 n-terminal isoforms in response to bone morphogenetic protein-2 during development of the osteoblast phenotype.
    Banerjee C; Javed A; Choi JY; Green J; Rosen V; van Wijnen AJ; Stein JL; Lian JB; Stein GS
    Endocrinology; 2001 Sep; 142(9):4026-39. PubMed ID: 11517182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory controls for osteoblast growth and differentiation: role of Runx/Cbfa/AML factors.
    Lian JB; Javed A; Zaidi SK; Lengner C; Montecino M; van Wijnen AJ; Stein JL; Stein GS
    Crit Rev Eukaryot Gene Expr; 2004; 14(1-2):1-41. PubMed ID: 15104525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smad function and intranuclear targeting share a Runx2 motif required for osteogenic lineage induction and BMP2 responsive transcription.
    Afzal F; Pratap J; Ito K; Ito Y; Stein JL; van Wijnen AJ; Stein GS; Lian JB; Javed A
    J Cell Physiol; 2005 Jul; 204(1):63-72. PubMed ID: 15573378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel regulators associated with early-phase osteoblast differentiation.
    de Jong DS; Vaes BL; Dechering KJ; Feijen A; Hendriks JM; Wehrens R; Mummery CL; van Zoelen EJ; Olijve W; Steegenga WT
    J Bone Miner Res; 2004 Jun; 19(6):947-58. PubMed ID: 15125793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12.
    Lee KS; Kim HJ; Li QL; Chi XZ; Ueta C; Komori T; Wozney JM; Kim EG; Choi JY; Ryoo HM; Bae SC
    Mol Cell Biol; 2000 Dec; 20(23):8783-92. PubMed ID: 11073979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional regulation of the human Runx2/Cbfa1 gene promoter by bone morphogenetic protein-7.
    Tou L; Quibria N; Alexander JM
    Mol Cell Endocrinol; 2003 Jul; 205(1-2):121-9. PubMed ID: 12890574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation.
    Lee MH; Javed A; Kim HJ; Shin HI; Gutierrez S; Choi JY; Rosen V; Stein JL; van Wijnen AJ; Stein GS; Lian JB; Ryoo HM
    J Cell Biochem; 1999 Apr; 73(1):114-25. PubMed ID: 10088730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BMP2-dependent gene regulatory network analysis reveals Klf4 as a novel transcription factor of osteoblast differentiation.
    Yu S; Guo J; Sun Z; Lin C; Tao H; Zhang Q; Cui Y; Zuo H; Lin Y; Chen S; Liu H; Chen Z
    Cell Death Dis; 2021 Feb; 12(2):197. PubMed ID: 33608506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Menin is required for bone morphogenetic protein 2- and transforming growth factor beta-regulated osteoblastic differentiation through interaction with Smads and Runx2.
    Sowa H; Kaji H; Hendy GN; Canaff L; Komori T; Sugimoto T; Chihara K
    J Biol Chem; 2004 Sep; 279(39):40267-75. PubMed ID: 15150273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient changes in oxygen tension inhibit osteogenic differentiation and Runx2 expression in osteoblasts.
    Salim A; Nacamuli RP; Morgan EF; Giaccia AJ; Longaker MT
    J Biol Chem; 2004 Sep; 279(38):40007-16. PubMed ID: 15263007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BMP2 commitment to the osteogenic lineage involves activation of Runx2 by DLX3 and a homeodomain transcriptional network.
    Hassan MQ; Tare RS; Lee SH; Mandeville M; Morasso MI; Javed A; van Wijnen AJ; Stein JL; Stein GS; Lian JB
    J Biol Chem; 2006 Dec; 281(52):40515-26. PubMed ID: 17060321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the ectodomain-releasing protease ADAM17 is directly regulated by the osteosarcoma and bone-related transcription factor RUNX2.
    Araya HF; Sepulveda H; Lizama CO; Vega OA; Jerez S; Briceño PF; Thaler R; Riester SM; Antonelli M; Salazar-Onfray F; Rodríguez JP; Moreno RD; Montecino M; Charbonneau M; Dubois CM; Stein GS; van Wijnen AJ; Galindo MA
    J Cell Biochem; 2018 Nov; 119(10):8204-8219. PubMed ID: 29923217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel regulatory role for stromal-derived factor-1 signaling in bone morphogenic protein-2 osteogenic differentiation of mesenchymal C2C12 cells.
    Zhu W; Boachie-Adjei O; Rawlins BA; Frenkel B; Boskey AL; Ivashkiv LB; Blobel CP
    J Biol Chem; 2007 Jun; 282(26):18676-85. PubMed ID: 17439946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.